TCRG Cannaisseur Group Inc.
Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1879270 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY78.2%
TTM EPS YoY100.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-162,372.1%
ROIC (approx.)—
Asset turnover0.00x
Leverage & solvency
Liabilities / assets2,151,675.0%
Debt / equity—
Current ratio0.00x
Interest coverage-403.02x
Cash quality & payout
Operating cash flow / net income0.28x
Accruals ratio-116,771.7%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $0 | $700 |
| Cost of revenue | $910 | $4,275 |
| Gross profit | -$910 | -$3,575 |
| SG&A expense | $1.72M | $1.26M |
| Operating income | -$1.72M | -$1.27M |
| Interest expense | $4,277 | $6,427 |
| Pretax income | -$1.81M | -$1.27M |
| Income tax | $0 | $0 |
| Net income | -$1.77M | -$1.27M |
| EBITDA | — | -$1.27M |
| EPS (basic) | -0.03 | -0.03 |
| EPS (diluted) | -0.03 | -0.03 |
| Weighted avg. shares (diluted) | 53.90M | 43.81M |
| Balance sheet | ||
| Cash & equivalents | $22 | $563 |
| Receivables | $0 | $285 |
| Inventory | $118 | $1,028 |
| Current assets | $140 | $1,876 |
| Total assets | $140 | $1,876 |
| Current liabilities | $210,632 | $229,113 |
| Total liabilities | $235,431 | $305,576 |
| Shareholders' equity | -$92,889 | -$233,639 |
| Shares outstanding | 60.46M | 44.34M |
| Cash flow statement | ||
| Operating cash flow | -$127,451 | -$110,627 |
| Financing cash flow | $126,910 | $72,800 |
| Depreciation & amortization | — | $0 |
| Stock-based compensation | $1.29M | $1.04M |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.